Roche Pharma AG (Germany) (Q335030): Difference between revisions

From geokb

Latest revision as of 15:31, 10 September 2024

company organization in Grenzach-Wyhlen, Germany

Roche Germany
Roche Pharma AG

Language	Label	Description	Also known as
English	Roche Pharma AG (Germany)	company organization in Grenzach-Wyhlen, Germany	Roche Germany Roche Pharma AG

Statements

0 references

addresses subject

Therapeutic Antibodies: Development, Engineering, and Applications

404

1 reference

https://openalex.org/I4210094361

Protein Aggregation and Biopharmaceutical Stability

197

1 reference

https://openalex.org/I4210094361

Mechanisms of Alzheimer's Disease

168

1 reference

https://openalex.org/I4210094361

Glycosylation in Health and Disease

145

1 reference

https://openalex.org/I4210094361

Recombinant Protein Production in Mammalian and Insect Cells

132

1 reference

https://openalex.org/I4210094361

Diagnosis and Management of Alzheimer's Disease

129

1 reference

https://openalex.org/I4210094361

Chimeric Antigen Receptor T Cell Therapy

129

1 reference

https://openalex.org/I4210094361

Immunogenicity of Biosimilar Therapeutics in Drug Development

103

1 reference

https://openalex.org/I4210094361

Management of Diabetes Mellitus and Hypoglycemia

94

1 reference

https://openalex.org/I4210094361

HER2 Signaling in Breast Cancer Treatment

90

1 reference

https://openalex.org/I4210094361

Cancer Immunotherapy

83

1 reference

https://openalex.org/I4210094361

Hepatitis C Infection and Treatment

73

1 reference

https://openalex.org/I4210094361

Role of Fibroblast Activation in Cancer Progression

72

1 reference

https://openalex.org/I4210094361

Immunobiology of Dendritic Cells

69

1 reference

https://openalex.org/I4210094361

DNA Nanotechnology and Bioanalytical Applications

66

1 reference

https://openalex.org/I4210094361

Lymphoid Neoplasms

63

1 reference

https://openalex.org/I4210094361

Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia

61

1 reference

https://openalex.org/I4210094361

Natural Killer Cells in Immunity

53

1 reference

https://openalex.org/I4210094361

Bisphosphonates in Cancer Treatment and Bone Health

49

1 reference

https://openalex.org/I4210094361

Genetics and Pathogenesis of Type 1 Diabetes

49

1 reference

https://openalex.org/I4210094361

Genomic Landscape of Cancer and Mutational Signatures

49

1 reference

https://openalex.org/I4210094361

Ribosome Structure and Translation Mechanisms

49

1 reference

https://openalex.org/I4210094361

Health Economics and Quality of Life Assessment

49

1 reference

https://openalex.org/I4210094361

Protein Microarray Technology and Applications

48

1 reference

https://openalex.org/I4210094361

Statistical Methods in Clinical Trials and Drug Development

48

1 reference

https://openalex.org/I4210094361

coordinate location

47°33'0"N, 7°41'0"E

1 reference

https://openalex.org/I4210094361

Federal Republic of Germany

1 reference

https://openalex.org/I4210094361

official website

https://www.roche.de

1 reference

https://openalex.org/I4210094361

0 references

Research Organization Registry ID

0 references

is subsidiary of

Roche (Switzerland)

1 reference

https://openalex.org/I4210094361

Retrieved from "https://geokb.wikibase.cloud/w/index.php?title=Item:Q335030&oldid=1271436"